Form EFFECT Neuphoria Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 27, 2024 |
| Accession Number: | 0001213900-24-112003 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Surf Air Mobility Signs OperatorOS Contract with SkyDance Air
- WYNDHAM HOTELS & RESORTS TO REPORT THIRD QUARTER 2026 EARNINGS ON OCTOBER 21, 2026
- Integra Identifies New Near-Mine Gold Growth Targets at Florida Canyon, including 1.30 g/t Au over 62.5 m and 0.59 g/t Au over 167.6 m Inter-Pit and 0.48 g/t Au over 54.9 m in New Madre Shear North Ta
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
